Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2026, 'Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trial', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70524
, 2026, 'Darier disease—A review highlighting new insights from the Darier Disease International Task Force', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70483
, 2026, 'Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS/TEN', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70578
, 2026, 'Long-Term Efficacy and Safety of Oleogel-S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis Bullosa', Pediatric Dermatology, http://dx.doi.org/10.1111/pde.70224
, 2026, 'Methodological concerns in the EASE study of Oleogel-S10 for epidermolysis bullosa: reply from authors', British Journal of Dermatology, 194, pp. 175 - 177, http://dx.doi.org/10.1093/bjd/ljaf365
, 2026, 'Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey', British Journal of Dermatology, 194, pp. 165 - 167, http://dx.doi.org/10.1093/bjd/ljaf366
, 2026, 'Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases', International Journal of Dermatology, 65, pp. 18 - 27, http://dx.doi.org/10.1111/ijd.17964
, 2026, 'Reassessing Remission in Pemphigus Vulgaris: Beyond Complete Remission Towards Meaningful Disease Control', International Journal of Dermatology, http://dx.doi.org/10.1111/ijd.70652
, 2026, 'Response to Hassan and Paas, “Curbing paper mills in departments and journals”', Journal of the American Academy of Dermatology, 94, pp. e61 - e62, http://dx.doi.org/10.1016/j.jaad.2025.09.071
, 2026, 'Response to methodological concerns in cumulative isotretinoin dose trials', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70719
, 2026, 'Space-related dermatoses', Clinics in Dermatology, 44, pp. 87 - 99, http://dx.doi.org/10.1016/j.clindermatol.2025.10.006
, 2026, 'Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study', British Journal of Dermatology, 194, pp. 163 - 165, http://dx.doi.org/10.1093/bjd/ljaf385
, 2026, 'Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosa', Expert Review of Clinical Pharmacology, 19, pp. 269 - 273, http://dx.doi.org/10.1080/17512433.2026.2641138
, 2026, '75974 Triggers for epidermolysis bullosa acquisita flares: A multi-database retrospective pharmacovigilance study', Journal of the American Academy of Dermatology, 95, pp. ab462, http://dx.doi.org/10.1016/j.jaad.2026.04.1837
, 2026, '75990 Risk of malignancies in patients with bullous pemphigoid; a case-control study', Journal of the American Academy of Dermatology, 95, pp. ab390, http://dx.doi.org/10.1016/j.jaad.2026.04.1555
, 2026, '76688 Long-term efficacy and safety of nemolizumab in adolescents with moderate-to-severe atopic dermatitis: Post hoc analyses from ARCADIA LTE 2-year cut-off', Journal of the American Academy of Dermatology, 95, pp. ab287, http://dx.doi.org/10.1016/j.jaad.2026.04.1158
, 2026, 'Advances in the diagnosis and epidemiology of anti-p200 pemphigoid.', J Eur Acad Dermatol Venereol, 40, pp. 1581 - 1582, http://dx.doi.org/10.1111/jdv.70667
, 2026, 'Glossed over: the increasing importance of ultraviolet-cured gel nail polish in allergic contact dermatitis', International Journal of Women's Dermatology, 12, pp. e267, http://dx.doi.org/10.1097/jw9.0000000000000267
, 2026, 'Rituximab for autoimmune blistering diseases in pregnancy and children: a clinical review', International Journal of Women's Dermatology, 12, pp. e270, http://dx.doi.org/10.1097/jw9.0000000000000270
, 2025, 'P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases', British Journal of Dermatology, 193, http://dx.doi.org/10.1093/bjd/ljaf465.030
, 2025, 'Author Correction: Bullous pemphigoid (Nature Reviews Disease Primers, (2025), 11, 1, (12), 10.1038/s41572-025-00595-5)', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00605-6
, 2025, 'Bullous pemphigoid', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00595-5
, 2025, 'Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation', Australasian Journal of Dermatology, 66, pp. 468 - 474, http://dx.doi.org/10.1111/ajd.14592
, 2025, 'Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: Results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)', British Journal of Dermatology, 193, pp. 1101 - 1111, http://dx.doi.org/10.1093/bjd/ljaf236
, 2025, 'Enhancing randomized clinical trials with digital twins', Npj Systems Biology and Applications, 11, http://dx.doi.org/10.1038/s41540-025-00592-0
, 2025, 'Morgellons disease: a review on current evidence and the need for consensus, standardized criteria, and future randomized controlled trials', Archives of Dermatological Research, 317, http://dx.doi.org/10.1007/s00403-025-04308-6
, 2025, 'Pilot Study of Tildrakizumab in the Treatment of Stable Non-Segmental Vitiligo', JEADV Clinical Practice, 4, pp. 1140 - 1145, http://dx.doi.org/10.1002/jvc2.70113
, 2025, 'Pioneers in Dermatology and Venereology: An interview with Professor Dedee F. Murrell', Journal of the European Academy of Dermatology and Venereology, 39, pp. 2032 - 2036, http://dx.doi.org/10.1111/jdv.70132
, 2025, 'Scoring systems for Mucous Membrane Pemphigoid – A review of the literature', SKINdeep, 1, http://dx.doi.org/10.1553/skindeep.2025.162540
, 2025, 'Erratum: Author Correction: Enhancing randomized clinical trials with digital twins (NPJ systems biology and applications (2025) 11 1 DOI: 10.1038/s41540-025-00592-0.)', Npj Systems Biology and Applications, 11, pp. 124, http://dx.doi.org/10.1038/s41540-025-00609-8
, 2025, 'A review of scoring instruments for the assessment of disease severity in epidermolysis bullosa acquisita', Dermatologica Sinica, 43, pp. 259 - 266, http://dx.doi.org/10.4103/ds.DS-D-25-00105
, 2025, 'Ofatumumab for the management of refractory pemphigus vulgaris: A case series', Jaad International, 22, pp. 94 - 96, http://dx.doi.org/10.1016/j.jdin.2025.05.018
, 2025, 'The Bipedicled Flap for Anterior Ingrown Toenail', Dermatologic Surgery, Publish Ahead of Print, http://dx.doi.org/10.1097/DSS.0000000000004866
, 2025, 'Photoallergic drug eruption secondary to oral terbinafine prescribed for management of tinea incognita', SKINdeep, 1, http://dx.doi.org/10.1553/skindeep.2025.153393
, 2025, 'Evaluation of the responsiveness of the Keratosis Pilaris Investigator Global Assessment Score (KP-IGA) and composite KP Area Index (KPAI)', British Journal of Dermatology, 193, pp. 556 - 558, http://dx.doi.org/10.1093/bjd/ljaf163
, 2025, 'Linear Focal Elastosis: What We Know From Epidemiological Studies', Australasian Journal of Dermatology, 66, pp. 364 - 368, http://dx.doi.org/10.1111/ajd.14569
, 2025, 'Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts', International Journal of Dermatology, 64, pp. 1546 - 1557, http://dx.doi.org/10.1111/ijd.17668
, 2025, 'Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa—Impact of Oleogel-S10', Journal of Dermatology, 52, pp. 1447 - 1451, http://dx.doi.org/10.1111/1346-8138.17884
, 2025, 'Space Oncology: A Comprehensive Scoping Review', Wilderness and Environmental Medicine, 36, pp. 148 - 171, http://dx.doi.org/10.1177/10806032251349442
, 2025, 'Dr. Dedee Murrell', The Nishinihon Journal of Dermatology, 87, pp. 369 - 370, http://dx.doi.org/10.2336/nishinihonhifu.87.369
, 2025, 'The Efficacy of Using Oral Sodium Cromoglycate for Controlling Epidermolysis Bullosa-Related Pruritus', Australasian Journal of Dermatology, 66, pp. 309 - 311, http://dx.doi.org/10.1111/ajd.14530
, 2025, 'Using Biologics to Reduce Long-Term Corticosteroid Use in Pyoderma Gangrenosum: Real-World Evidence From Two Centres', Australasian Journal of Dermatology, 66, pp. 305 - 308, http://dx.doi.org/10.1111/ajd.14532
, 2025, 'Colchicine as a treatment option for inherited epidermolysis bullosa', Clinical and Experimental Dermatology, 50, pp. 1238 - 1240, http://dx.doi.org/10.1093/ced/llaf016
, 2025, 'Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study', British Journal of Dermatology, 192, pp. 1007 - 1017, http://dx.doi.org/10.1093/bjd/ljaf022
, 2025, 'Translation, cultural adaptation and validation of the German Quality of Life in Epidermolysis Bullosa (QOLEB) questionnaire', Journal of Health Psychology, 30, pp. 1476 - 1490, http://dx.doi.org/10.1177/13591053231221369
, 2025, 'Dermatologic manifestations of hereditary hemochromatosis: A systematic review', Journal of the European Academy of Dermatology and Venereology, 39, pp. 976 - 986, http://dx.doi.org/10.1111/jdv.20098
, 2025, 'Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires', Journal of Dermatology, 52, pp. 812 - 830, http://dx.doi.org/10.1111/1346-8138.17707
, 2025, 'Leveraging space innovations for cancer breakthroughs on Earth', Trends in Cancer, 11, pp. 433 - 440, http://dx.doi.org/10.1016/j.trecan.2025.02.003
, 2025, 'The development and validation of an investigator global assessment score for keratosis pilaris', Journal of the European Academy of Dermatology and Venereology, 39, pp. e350 - e352, http://dx.doi.org/10.1111/jdv.20326
, 2025, 'Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece', Jid Innovations, 5, http://dx.doi.org/10.1016/j.xjidi.2024.100339